Prozkoumejte nejčtenější články a videa na Campus Sanofi
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).
Think Fabry, think timely testing first.
Think Fabry, think regular profile-based assessments.